Novavax is headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease. More...
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. More...
In the News
Careers at Novavax
Are you ready to work for one of Washington's Top Workplaces? We welcome your interest in joining our team and creating tomorrow’s vaccines. Novavax is a fast-paced company that provides employees with opportunities for professional growth, as well as the flexibility to achieve a balance between work and personal life. We invite you to apply for our open positions.
Click here to see a list of open positions.